Navigation Links
Biota makes major antiviral discovery

Biota Holdings Limited announced today that it has discovered a new class of orally-effective, potent antivirals against RSV (respiratory syncytial virus) infection. Biota has filed worldwide patents and selected a lead candidate with a series of backups for further preclinical development prior to human clinical trials.

RSV infection is an important medical need and already a billion-dollar market, with growing visibility among pharmaceutical companies. The currently marketed drug is an injectable antibody with 2004 sales of approximately US$1 billion ($1.3 billion). However, its use is limited to prevention of infection, not treatment, and it is currently only approved for use in the highest risk group of patients: premature infants. If successful, the Biota RSV drug is expected to have significant advantages and could expand the market to include treatment as well as prevention and to other 'at risk' patient segments, such as children, the elderly and people with underlying respiratory conditions.

Latest results in two animal models also demonstrate that Biota's new RSV antivirals are effective when administered orally. This should allow the product to be developed in a convenient oral formulation, such as a tablet or suspension.

"The discovery of a novel, orally available RSV antiviral is a major achievement," said Dr Simon Tucker, Vice President of Research for Biota. "Others, including several large pharmaceutical companies, have discovered and disclosed RSV antivirals, but many are inhaled products. Orally effective RSV compounds appear to be a rarity. This is an exciting achievement for Biota and Australian research."

The current compounds are the result of research conducted by the Biota team over several years. Since 2003, this research has been supported by a $2.7m R&D Start grant from the Australian government. The RSV development follows on the heels of the company's recent decision to advance its common cold (human rh inovirus, HRV) drug candidate into clinical development following a similarly successful in-house research program.



Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. Grass makes environmentally friendly biofuel
3. Shampoo detergent added to paint makes surfaces self-sterilizing
4. Green diesel: New process makes liquid transportation fuel from plants
5. Discovery that bacterium is phosphate gourmet key clue to what makes it most social of bacteria
6. Technique makes it easier to see mouse embryo in all its glory
7. In the minds eye: How the brain makes a whole out of parts
8. African parasite makes component of fat differently from all other organisms
9. Coffee makes us more likely to say yes
10. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
11. Embryonic patterning makes the feathers fly
Post Your Comments:

(Date:9/30/2015)... , Sept. 30, 2015  With nearly 300,000 Americans ... of new SCIs estimated to reach 12,500 annually, the ... California Resource Services for Independent Living (SCRS-IL) is ... California opening doors to independence ... programs and services, notably assistive technology services and education. ...
(Date:9/29/2015)... 29, 2015 News facts: ... also saving energy , Minimized design shrinks PC ... Active Mode and embedded Fujitsu PalmSecure authentication enable enterprises ... Fujitsu today shows that good things come in small ... to its enterprise desktop and mobile portfolio. Featuring workplace ...
(Date:9/28/2015)... YORK , Sept. 28, 2015  The ... respiration rate and body temperature, is an essential ... can be indicators of deterioration in a patient,s ... hospital, vital signs are typically taken during routine ... hours. If a patient deteriorates between these observation ...
Breaking Biology News(10 mins):
(Date:10/12/2015)... PHILADELPHIA , October 12, 2015 ... alternative to print version for enriched online experience ... media alternative to print version for enriched online ... offers user-friendly, multi media alternative to print version ... a world-leading provider of scientific, technical and medical information ...
(Date:10/11/2015)... ... October 11, 2015 , ... Intelligent Implant Systems, ... launched and multiple surgeries have been completed with this new posterior thoracolumbar spinal ... & Spine Center of the Carolinas. The Revolution™ Spinal System pioneers a ...
(Date:10/9/2015)... and ROCKVILLE, Md. ... ("ITI"), a privately-held biotechnology company developing next generation ... that it has entered into an exclusive worldwide ... products for the treatment or prevention of any ... of the agreement, Immunomic Therapeutics will receive an ...
(Date:10/8/2015)... CARDIFF, UK (PRWEB) , ... October 08, 2015 , ... ... to literally see inside the living brain, providing a new tool to study how ... work is reported by Woo June Choi and Ruikang Wang of the UW Department ...
Breaking Biology Technology: